Validity of Diagnostic Algorithms for Cardiovascular Diseases in Japanese Health Insurance Claims-Reference-Cited by-同舟云学术

Validity of Diagnostic Algorithms for Cardiovascular Diseases in Japanese Health Insurance Claims

Published:2023-03-24 Issue:4 Volume:87 Page:536-542
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Kanaoka Koshiro¹,Iwanaga Yoshitaka¹,Okada Katsuki²,Terasaki Satoshi³,Nishioka Yuichi⁴,Nakai Michikazu¹,Kamon Daisuke³,Myojin Tomoya⁴,Soeda Tsunenari³,Noda Tatsuya⁴,Horii Manabu⁵,Sakata Yasushi²,Miyamoto Yoshihiro⁶,Saito Yoshihiko³,Imamura Tomoaki⁴

Affiliation:

1. Department of Medical and Health Information Management, National Cerebral and Cardiovascular Center

2. Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine

3. Department of Cardiovascular Medicine, Nara Medical University

4. Department of Public Health, Health Management and Policy, Nara Medical University

5. Department of Cardiovascular Medicine, Nara City Hospital

6. Open Innovation Center, National Cerebral and Cardiovascular Center

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/87/4/87_CJ-22-0566/_pdf

Reference22 articles.

1. 1. Ministry of Health, Labour and Welfare. The Ministry of Health population movement statistics [in Japanese]. https://www.mhlw.go.jp/toukei/list/81-1.html (accessed February 14, 2022).

2. 2. Naghavi M, Abajobir AA, Abbafati C, Abbas KM, Abd-Allah F, Abera SF, et al. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017; 390: 1151–1210, doi:10.1016/s0140-6736(17)32152-9.

3. 3. Kanaoka K, Okayama S, Nakai M, Sumita Y, Nishimura K, Kawakami R, et al. Hospitalization costs for patients with acute congestive heart failure in Japan. Circ J 2019; 83: 1025–1031, doi:10.1253/circj.CJ-18-1212.

4. 4. Snyder JM, Pawloski JA, Poisson LM. Developing real-world evidence-ready datasets: Time for clinician engagement. Curr Oncol Rep 2020; 22: 45, doi:10.1007/s11912-020-00904-z.

5. 5. Schneeweiss S, Avorn J. A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol 2005; 58: 323–337, doi:10.1016/j.jclinepi.2004.10.012.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Usefulness and caveats of real-world data for research on hypertension and its association with cardiovascular or renal disease in Japan;Hypertension Research;2024-09-11

2. Postdischarge functional outcomes in older patients with acute heart failure in Japan: the Longevity Improvement & Fair Evidence study;Age and Ageing;2024-07

3. No standard modifiable cardiovascular risk factors in acute myocardial infarction: prevalence, pathophysiology, and prognosis;Cardiovascular Intervention and Therapeutics;2024-06-17

4. Prognostic Value of Objective Social Isolation and Loneliness in Older Patients With Heart Failure: Subanalysis of FRAGILE‐HF and Kitasato Cohort;Journal of the American Heart Association;2024-05-21

5. Clinical Efficacy of Beta-1 Selective Beta-Blockers Versus Propranolol in Patients With Thyroid Storm: A Retrospective Cohort Study*;Critical Care Medicine;2024-03-29